COMP <GO>
KRMD vs UNH // EV/EBITDA & P/E VALUATION
KORU Medical Systems Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: KRMD 2
— UNH 8
■ METRIC PARITY
LAST: $3.23 (+0.31%) • MKT CAP: $149.1M
valuation
—
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
valuation
16.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KRMD VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KRMD | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.30% | 88.57% | -26.27 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -28.70% | 11.47% | -40.17 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.31% | 6.48% | -6.17 | UNH | /fcf-yield <GO> |
| Operating Margin | -7.20% | 4.82% | -12.02 | UNH | /operating-margins <GO> |
| Net Profit Margin | -6.40% | 3.14% | -9.54 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 22.20% | 6.46% | +15.74 | KRMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.05 | 3.12 | +4.93 | KRMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.8 | 59.2 | -3.40 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $149.1M | $368.83B | -$368.68B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KRMD REV | UNH REV | KRMD GROSS % | UNH GROSS % | KRMD FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $41.1M | $447.57B | 62.3% | 88.7% | $462.4K | $16.07B |
| FY 2024 | $33.6M | $400.28B | 63.4% | 88.3% | -$319.7K | $20.70B |
| FY 2023 | $28.5M | $371.62B | — | 89.6% | -$4.9M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KRMD // BETA —
UNH // BETA 0.33